Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
NCT04292535Phase 2Completed
- Sponsor
- Michigan State University
- Start
- Jun 2018
- Primary completion
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of insulin aspart in Alzheimer's disease (AD), Dementia, sponsored by Michigan State University. Started Jun 2018; status: completed.
02
Drugs
insulin aspart
03
Conditions
Alzheimer's disease (AD)Dementia
Beyond the preview
Go deeper on NCT04292535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04292535.